Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia

por Greenfield, Graeme, McMullan, Ross, Robson, Nuala, McGimpsey, Julie, Catherwood, Mark, McMullin, Mary Frances
Publicado 2019

NEMHESYS—European Perspective on the Implementation of Next-generation Sequencing Into Clinical Diagnostics

por Serramito-Gómez, Inmaculada, Clarke, Kathryn M., Rodríguez-Vicente, Ana Eugenia, McGimpsey, Julie E., Abáigar, María, Díez, Carlos Barranquero, Benito, Rocío, Bullinger, Lars, Mills, Ken I., Hernández Rivas, Jesús María
Publicado 2021